ABG
Ally Bridge Group’s Enliven Therapeutics ELVN Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $5.64M | Buy |
281,394
+111,620
| +66% | +$2.24M | 4.7% | 5 |
|
|
2025
Q1 | $3.34M | Buy |
169,774
+28,064
| +20% | +$552K | 3.01% | 11 |
|
|
2024
Q4 | $3.19M | Sell |
141,710
-93,146
| -40% | -$2.1M | 2.73% | 16 |
|
|
2024
Q3 | $6M | Buy |
+234,856
| New | +$6M | 3.21% | 15 |
|